Adderall use and the risk of fractures in the pediatric population: a retrospective cohort study
DOI:
https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20261199Keywords:
ADHD, Amphetamine, Distal radius, Dextroamphetamine, Pediatric fractures, Supracondylar humerusAbstract
Background: Children with attention-deficit/hyperactivity disorder (ADHD) experience higher injury rates than their peers, but the effect of stimulant therapy on fracture risk remains uncertain. To evaluate the association between amphetamine exposure and incident fractures of the distal radius, supracondylar humerus and clavicle in youth with ADHD.
Methods: Retrospective cohort study using the TriNetX global collaborative network. Patients aged 6–18 years with ADHD (ICD-10-CM F90) were classified as amphetamine-exposed (prescribed dextroamphetamine or amphetamine within six months of index) or unexposed. Outcomes were new distal radius (S52.5), supracondylar humerus (S42.41) and clavicle (S42.0) fractures. Incidence, risk ratios and hazard ratios were estimated with Kaplan–Meier and Cox models.
Results: After matching (n=226,620; 113,310 per cohort), amphetamine exposure was associated with significantly lower 30-day fracture risk. Distal radius fractures occurred in 0.44% of exposed vs 0.72% unexposed (RD −0.28%, RR 0.61, 95% CI 0.55–0.69, HR 0.46, 95% CI 0.41–0.51, p<0.001). Supracondylar fractures occurred in 0.04% vs 0.08% (RD −0.04%, RR 0.51, 95% CI 0.36–0.72, HR 0.41, 95% CI 0.29–0.57, p<0.001). Clavicle fracture risk was similar between cohorts (0.18% vs 0.21%, RD−0.03%, RR 0.76, 95% CI 0.63–0.93, p=0.084), although HR remained significant (HR 0.63, 95% CI 0.52–0.76, p<0.001).
Conclusions: Among children and adolescents with ADHD, amphetamine exposure was associated with significantly lower fracture incidence and hazard for distal radius, supracondylar humerus and clavicle injuries. These findings suggest stimulant treatment may reduce specific orthopaedic injuries and merit further investigation.
References
Karl Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):994-1001.
Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, et al. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789-818.
Berridge CW, Devilbiss DM. Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines and attention-deficit/hyperactivity disorder. Biol Psychiatry. 2011;69(12):101-11.
Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727-38.
Ruiz-Goikoetxea M, Cortese S, Aznarez-Sanado M, Magallón S, Alvarez Zallo N, Luis EO, et al. Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2018;84:63-71.
Zhang SW, Shen D, Yan YT. ADHD, stimulant medication use and the risk of fracture: a systematic review and meta-analysis. Arch Osteoporos. 2021;16(1):81.
Khosla S, Melton LJ 3rd, Dekutoski MB, Achenbach SJ, Oberg AL, Riggs BL. Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA. 2003;290(11):1479-85.
Chang Z, Quinn PD, Hur K, Gibbons RD, Sjölander A, Larsson H, et al. Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes. JAMA Psychiat. 2017;74(6):597-603.
Cooper C, Dennison EM, Leufkens HG, Bishop N, van Staa TP. Epidemiology of childhood fractures in Britain: a study using the general practice research database. J Bone Miner Res. 2004;19(12):1976-81.
Austin PC. An Introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399-424.
Hernán MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183(8):758-64.
Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. Record working committee. the reporting of studies conducted using observational routinely-collected health data (record) statement. PLoS Med. 2015;12(10):1001885.
Dalsgaard S, Leckman JF, Mortensen PB, Nielsen HS, Simonsen M. Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study. Lancet Psychiatry. 2015;2(8):702-9.
Chang Z, Quinn PD, O'Reilly L, Sjölander A, Hur K, Gibbons R, et al. Medication for attention-deficit/hyperactivity disorder and risk for suicide attempts. Biol Psychiatry. 2020;88(6):452-8.
Arnsten AF. Catecholamine influences on dorsolateral prefrontal cortical networks. Biol Psychiat. 2011;69(12):89-99.
Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task. Neuropharmacology. 2009;57(8):640-52.
Milewski MD, Skaggs DL, Bishop GA, Pace JL, Ibrahim DA, Wren TA, et al. Chronic lack of sleep is associated with increased sports injuries in adolescent athletes. J Pediatr Orthop. 2014;34(2):129-33.
Bland JM, Altman DG. The logrank test. BMJ. 2004;328(7447):1073.
Poulton A, Cowell CT. Slowing of growth in height and weight on stimulants: a characteristic pattern. J Paediatr Child Health. 2003;39(3):180-5.
Soligard T, Myklebust G, Steffen K, Holme I, Silvers H, Bizzini M, et al. Comprehensive warm-up programme to prevent injuries in young female footballers: cluster randomised controlled trial. BMJ. 2008;337:2469.
Downloads
Published
How to Cite
Issue
Section
